Renflexis 100 MG vials
Ended Awarded
- Contract number
- SPE2DB25FQ94S
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $25,956
Award facts
- Contract value 100% obligated
- $25,955.80 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $25,955.80 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 100 mg vials of Renflexis, a pharmaceutical product used in military and federal healthcare supply chains. This non-set-aside contract was awarded on September 26, 2025, with an ultimate completion date of September 29, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a routine procurement action within the company's existing relationship with the Defense Logistics Agency for pharmaceutical supplies.
This award is a child contract issued under AmerisourceBergen's substantial Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of medications, vaccines, and medical supplies to support military healthcare programs and defense health systems worldwide. AmerisourceBergen's federal contract portfolio demonstrates its established capability as a critical pharmaceutical distributor for military and veteran healthcare procurement, consistently delivering competitively awarded orders with firm fixed pricing across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DB25FQ94S?
SPE2DB25FQ94S was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 26, 2025.
How much is contract SPE2DB25FQ94S worth?
The government has obligated $25,956 on SPE2DB25FQ94S.
Is contract SPE2DB25FQ94S an order under another contract?
Yes. SPE2DB25FQ94S is a delivery order under SPE2DB22D3004, an indefinite delivery contract.
Was contract SPE2DB25FQ94S competed?
The extent of competition for SPE2DB25FQ94S was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award